Global Deferasirox Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Publisher Name :
Date: 25-Feb-2019
No. of pages: 104

Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta- thalassemia and other chronic anemias.

Scope of the Report:

The half-life of deferasirox is between 8 and 16 hours allowing once a day dosing. Two molecules of deferasirox are capable of binding to 1 atom of iron which is subsequently eliminated by fecal excretion. Its low molecular weight and high lipophilicity allows the drug to be taken orally unlike deferoxamine which has to be administered by IV route (intravenous infusion). Together with deferiprone, deferasirox seems to be capable of removing iron from cells (cardiac myocytes and hepatocytes) as well as removing iron from the blood.- - - - - Consumers are generally quick-change, to get or use newfangled products, better experience, better convenience and more quicker; to find and meet the needs of consumers, and exceeding expectation, better service.

The worldwide market for Deferasirox is expected to grow at a CAGR of roughly 4.7% over the next five years, will reach 2990 million US$ in 2024, from 2270 million US$ in 2019, according to a new GIR (Global Info Research) study.

This report focuses on the Deferasirox in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

- Novartis

- Cipla

- Sun Pharma

- Natco Pharma

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- 500 mg/Tablet

- 250 mg/Tablet

- 125 mg/Tablet

- Others

Market Segment by Applications, can be divided into

- Transfusional Iron Overload

- NTDT Caused Iron Overload

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Deferasirox product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Deferasirox, with price, sales, revenue and global market share of Deferasirox in 2017 and 2018.

Chapter 3, the Deferasirox competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Deferasirox breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Deferasirox market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Deferasirox sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Global Deferasirox Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Market Overview
1.1 Deferasirox Introduction
1.2 Market Analysis by Type
1.2.1 500 mg/Tablet
1.2.2 250 mg/Tablet
1.2.3 125 mg/Tablet
1.2.4 Others
1.3 Market Analysis by Applications
1.3.1 Transfusional Iron Overload
1.3.2 NTDT Caused Iron Overload
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.2 Deferasirox Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis Deferasirox Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Cipla
2.2.1 Business Overview
2.2.2 Deferasirox Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Cipla Deferasirox Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Sun Pharma
2.3.1 Business Overview
2.3.2 Deferasirox Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sun Pharma Deferasirox Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Natco Pharma
2.4.1 Business Overview
2.4.2 Deferasirox Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Natco Pharma Deferasirox Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Deferasirox Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Deferasirox Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Deferasirox Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Deferasirox Manufacturer Market Share in 2018
3.3.2 Top 6 Deferasirox Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Deferasirox Market Analysis by Regions
4.1 Global Deferasirox Sales, Revenue and Market Share by Regions
4.1.1 Global Deferasirox Sales and Market Share by Regions (2014-2019)
4.1.2 Global Deferasirox Revenue and Market Share by Regions (2014-2019)
4.2 North America Deferasirox Sales and Growth Rate (2014-2019)
4.3 Europe Deferasirox Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Deferasirox Sales and Growth Rate (2014-2019)
4.5 South America Deferasirox Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Deferasirox Sales and Growth Rate (2014-2019)
5 North America Deferasirox by Country
5.1 North America Deferasirox Sales, Revenue and Market Share by Country
5.1.1 North America Deferasirox Sales and Market Share by Country (2014-2019)
5.1.2 North America Deferasirox Revenue and Market Share by Country (2014-2019)
5.2 United States Deferasirox Sales and Growth Rate (2014-2019)
5.3 Canada Deferasirox Sales and Growth Rate (2014-2019)
5.4 Mexico Deferasirox Sales and Growth Rate (2014-2019)
6 Europe Deferasirox by Country
6.1 Europe Deferasirox Sales, Revenue and Market Share by Country
6.1.1 Europe Deferasirox Sales and Market Share by Country (2014-2019)
6.1.2 Europe Deferasirox Revenue and Market Share by Country (2014-2019)
6.2 Germany Deferasirox Sales and Growth Rate (2014-2019)
6.3 UK Deferasirox Sales and Growth Rate (2014-2019)
6.4 France Deferasirox Sales and Growth Rate (2014-2019)
6.5 Russia Deferasirox Sales and Growth Rate (2014-2019)
6.6 Italy Deferasirox Sales and Growth Rate (2014-2019)
7 Asia-Pacific Deferasirox by Country
7.1 Asia-Pacific Deferasirox Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Deferasirox Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Deferasirox Revenue and Market Share by Country (2014-2019)
7.2 China Deferasirox Sales and Growth Rate (2014-2019)
7.3 Japan Deferasirox Sales and Growth Rate (2014-2019)
7.4 Korea Deferasirox Sales and Growth Rate (2014-2019)
7.5 India Deferasirox Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Deferasirox Sales and Growth Rate (2014-2019)
8 South America Deferasirox by Country
8.1 South America Deferasirox Sales, Revenue and Market Share by Country
8.1.1 South America Deferasirox Sales and Market Share by Country (2014-2019)
8.1.2 South America Deferasirox Revenue and Market Share by Country (2014-2019)
8.2 Brazil Deferasirox Sales and Growth Rate (2014-2019)
8.3 Argentina Deferasirox Sales and Growth Rate (2014-2019)
8.4 Colombia Deferasirox Sales and Growth Rate (2014-2019)
9 Middle East and Africa Deferasirox by Countries
9.1 Middle East and Africa Deferasirox Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Deferasirox Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Deferasirox Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Deferasirox Sales and Growth Rate (2014-2019)
9.3 Turkey Deferasirox Sales and Growth Rate (2014-2019)
9.4 Egypt Deferasirox Sales and Growth Rate (2014-2019)
9.5 Nigeria Deferasirox Sales and Growth Rate (2014-2019)
9.6 South Africa Deferasirox Sales and Growth Rate (2014-2019)
10 Global Deferasirox Market Segment by Type
10.1 Global Deferasirox Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Deferasirox Sales and Market Share by Type (2014-2019)
10.1.2 Global Deferasirox Revenue and Market Share by Type (2014-2019)
10.2 500 mg/Tablet Sales Growth and Price
10.2.1 Global 500 mg/Tablet Sales Growth (2014-2019)
10.2.2 Global 500 mg/Tablet Price (2014-2019)
10.3 250 mg/Tablet Sales Growth and Price
10.3.1 Global 250 mg/Tablet Sales Growth (2014-2019)
10.3.2 Global 250 mg/Tablet Price (2014-2019)
10.4 125 mg/Tablet Sales Growth and Price
10.4.1 Global 125 mg/Tablet Sales Growth (2014-2019)
10.4.2 Global 125 mg/Tablet Price (2014-2019)
10.5 Others Sales Growth and Price
10.5.1 Global Others Sales Growth (2014-2019)
10.5.2 Global Others Price (2014-2019)
11 Global Deferasirox Market Segment by Application
11.1 Global Deferasirox Sales Market Share by Application (2014-2019)
11.2 Transfusional Iron Overload Sales Growth (2014-2019)
11.3 NTDT Caused Iron Overload Sales Growth (2014-2019)
12 Deferasirox Market Forecast (2019-2024)
12.1 Global Deferasirox Sales, Revenue and Growth Rate (2019-2024)
12.2 Deferasirox Market Forecast by Regions (2019-2024)
12.2.1 North America Deferasirox Market Forecast (2019-2024)
12.2.2 Europe Deferasirox Market Forecast (2019-2024)
12.2.3 Asia-Pacific Deferasirox Market Forecast (2019-2024)
12.2.4 South America Deferasirox Market Forecast (2019-2024)
12.2.5 Middle East and Africa Deferasirox Market Forecast (2019-2024)
12.3 Deferasirox Market Forecast by Type (2019-2024)
12.3.1 Global Deferasirox Sales Forecast by Type (2019-2024)
12.3.2 Global Deferasirox Market Share Forecast by Type (2019-2024)
12.4 Deferasirox Market Forecast by Application (2019-2024)
12.4.1 Global Deferasirox Sales Forecast by Application (2019-2024)
12.4.2 Global Deferasirox Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Deferasirox Picture
Table Product Specifications of Deferasirox
Figure Global Sales Market Share of Deferasirox by Types in 2018
Table Deferasirox Types for Major Manufacturers
Figure 500 mg/Tablet Picture
Figure 250 mg/Tablet Picture
Figure 125 mg/Tablet Picture
Figure Others Picture
Figure Deferasirox Sales Market Share by Applications in 2018
Figure Transfusional Iron Overload Picture
Figure NTDT Caused Iron Overload Picture
Figure United States Deferasirox Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Deferasirox Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Deferasirox Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Deferasirox Revenue (Value) and Growth Rate (2014-2024)
Figure France Deferasirox Revenue (Value) and Growth Rate (2014-2024)
Figure UK Deferasirox Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Deferasirox Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Deferasirox Revenue (Value) and Growth Rate (2014-2024)
Figure China Deferasirox Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Deferasirox Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Deferasirox Revenue (Value) and Growth Rate (2014-2024)
Figure India Deferasirox Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Deferasirox Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Deferasirox Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Deferasirox Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Deferasirox Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Deferasirox Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Deferasirox Revenue (Value) and Growth Rate (2014-2024)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Deferasirox Type and Applications
Table Novartis Deferasirox Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Cipla Basic Information, Manufacturing Base and Competitors
Table Cipla Deferasirox Type and Applications
Table Cipla Deferasirox Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Sun Pharma Basic Information, Manufacturing Base and Competitors
Table Sun Pharma Deferasirox Type and Applications
Table Sun Pharma Deferasirox Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Natco Pharma Basic Information, Manufacturing Base and Competitors
Table Natco Pharma Deferasirox Type and Applications
Table Natco Pharma Deferasirox Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Deferasirox Sales by Manufacturer (2017-2018)
Figure Global Deferasirox Sales Market Share by Manufacturer in 2017
Figure Global Deferasirox Sales Market Share by Manufacturer in 2018
Table Global Deferasirox Revenue by Manufacturer (2017-2018)
Figure Global Deferasirox Revenue Market Share by Manufacturer in 2017
Figure Global Deferasirox Revenue Market Share by Manufacturer in 2018
Figure Top 3 Deferasirox Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Deferasirox Manufacturer (Revenue) Market Share in 2018
Figure Global Deferasirox Sales and Growth Rate (2014-2019)
Figure Global Deferasirox Revenue and Growth Rate (2014-2019)
Table Global Deferasirox Sales by Regions (2014-2019)
Table Global Deferasirox Sales Market Share by Regions (2014-2019)
Table Global Deferasirox Revenue by Regions (2014-2019)
Figure Global Deferasirox Revenue Market Share by Regions in 2014
Figure Global Deferasirox Revenue Market Share by Regions in 2018
Figure North America Deferasirox Sales and Growth Rate (2014-2019)
Figure Europe Deferasirox Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Deferasirox Sales and Growth Rate (2014-2019)
Figure South America Deferasirox Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Deferasirox Sales and Growth Rate (2014-2019)
Figure North America Deferasirox Revenue and Growth Rate (2014-2019)
Table North America Deferasirox Sales by Countries (2014-2019)
Table North America Deferasirox Sales Market Share by Countries (2014-2019)
Figure North America Deferasirox Sales Market Share by Countries in 2014
Figure North America Deferasirox Sales Market Share by Countries in 2018
Table North America Deferasirox Revenue by Countries (2014-2019)
Table North America Deferasirox Revenue Market Share by Countries (2014-2019)
Figure North America Deferasirox Revenue Market Share by Countries in 2014
Figure North America Deferasirox Revenue Market Share by Countries in 2018
Figure United States Deferasirox Sales and Growth Rate (2014-2019)
Figure Canada Deferasirox Sales and Growth Rate (2014-2019)
Figure Mexico Deferasirox Sales and Growth Rate (2014-2019)
Figure Europe Deferasirox Revenue and Growth Rate (2014-2019)
Table Europe Deferasirox Sales by Countries (2014-2019)
Table Europe Deferasirox Sales Market Share by Countries (2014-2019)
Table Europe Deferasirox Revenue by Countries (2014-2019)
Figure Europe Deferasirox Revenue Market Share by Countries in 2017
Figure Europe Deferasirox Revenue Market Share by Countries in 2018
Figure Germany Deferasirox Sales and Growth Rate (2014-2019)
Figure UK Deferasirox Sales and Growth Rate (2014-2019)
Figure France Deferasirox Sales and Growth Rate (2014-2019)
Figure Russia Deferasirox Sales and Growth Rate (2014-2019)
Figure Italy Deferasirox Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Deferasirox Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Deferasirox Sales by Countries (2014-2019)
Table Asia-Pacific Deferasirox Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Deferasirox Sales Market Share by Countries 2018
Table Asia-Pacific Deferasirox Revenue by Countries (2014-2019)
Figure Asia-Pacific Deferasirox Revenue Market Share by Countries 2018
Figure China Deferasirox Sales and Growth Rate (2014-2019)
Figure Japan Deferasirox Sales and Growth Rate (2014-2019)
Figure Korea Deferasirox Sales and Growth Rate (2014-2019)
Figure India Deferasirox Sales and Growth Rate (2014-2019)
Figure Southeast Asia Deferasirox Sales and Growth Rate (2014-2019)
Figure South America Deferasirox Revenue and Growth Rate (2014-2019)
Table South America Deferasirox Sales by Countries (2014-2019)
Table South America Deferasirox Sales Market Share by Countries (2014-2019)
Figure South America Deferasirox Sales Market Share by Countries in 2018
Table South America Deferasirox Revenue by Countries (2014-2019)
Table South America Deferasirox Revenue Market Share by Countries (2014-2019)
Figure South America Deferasirox Revenue Market Share by Countries in 2018
Figure Brazil Deferasirox Sales and Growth Rate (2014-2019)
Figure Argentina Deferasirox Sales and Growth Rate (2014-2019)
Figure Colombia Deferasirox Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Deferasirox Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Deferasirox Sales by Countries (2014-2019)
Table Middle East and Africa Deferasirox Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Deferasirox Sales Market Share by Countries in 2018
Table Middle East and Africa Deferasirox Revenue by Countries (2014-2019)
Table Middle East and Africa Deferasirox Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Deferasirox Revenue Market Share by Countries in 2014
Figure Middle East and Africa Deferasirox Revenue Market Share by Countries in 2018
Figure Saudi Arabia Deferasirox Sales and Growth Rate (2014-2019)
Figure UAE Deferasirox Sales and Growth Rate (2014-2019)
Figure Egypt Deferasirox Sales and Growth Rate (2014-2019)
Figure Nigeria Deferasirox Sales and Growth Rate (2014-2019)
Figure South Africa Deferasirox Sales and Growth Rate (2014-2019)
Table Global Deferasirox Sales by Type (2014-2019)
Table Global Deferasirox Sales Share by Type (2014-2019)
Table Global Deferasirox Revenue by Type (2014-2019)
Table Global Deferasirox Revenue Share by Type (2014-2019)
Figure Global 500 mg/Tablet Sales Growth (2014-2019)
Figure Global 500 mg/Tablet Price (2014-2019)
Figure Global 250 mg/Tablet Sales Growth (2014-2019)
Figure Global 250 mg/Tablet Price (2014-2019)
Figure Global 125 mg/Tablet Sales Growth (2014-2019)
Figure Global 125 mg/Tablet Price (2014-2019)
Figure Global Others Sales Growth (2014-2019)
Figure Global Others Price (2014-2019)
Table Global Deferasirox Sales by Application (2014-2019)
Table Global Deferasirox Sales Share by Application (2014-2019)
Figure Global NTDT Caused Iron Overload Sales Growth (2014-2019)
Figure Global Deferasirox Sales, Revenue and Growth Rate (2019-2024)
Table Global Deferasirox Sales Forecast by Regions (2019-2024)
Table Global Deferasirox Market Share Forecast by Regions (2019-2024)
Figure North America Sales Deferasirox Market Forecast (2019-2024)
Figure Europe Sales Deferasirox Market Forecast (2019-2024)
Figure Asia-Pacific Sales Deferasirox Market Forecast (2019-2024)
Figure South America Sales Deferasirox Market Forecast (2019-2024)
Figure Middle East and Africa Sales Deferasirox Market Forecast (2019-2024)
Table Global Deferasirox Sales Forecast by Type (2019-2024)
Table Global Deferasirox Market Share Forecast by Type (2019-2024)
Table Global Deferasirox Sales Forecast by Application (2019-2024)
Table Global Deferasirox Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
  • Global Penicillin and Streptomycin Market Professional Survey Report 2019
    Published: 20-Nov-2019        Price: US 3500 Onwards        Pages: 114
    The global Penicillin and Streptomycin market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Penicillin and Streptomycin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Penicillin and Streptomycin market size by analyzing historical data and future prospect. Regionally, this report categorizes the produ......
  • Global Histone Deacetylase (HDAC) Inhibitors Market Professional Survey Report 2019
    Published: 20-Nov-2019        Price: US 3500 Onwards        Pages: 114
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Histone Deacetylase (HDAC) Inhibitors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Histone Deacetylase (HDAC) Inhibitors market size by analyzing historical data and future prospect. Regionally, thi......
  • Global Atropine Market Growth 2019-2024
    Published: 20-Nov-2019        Price: US 3660 Onwards        Pages: 163
    According to this study, over the next five years the Atropine market will register a -1.8% CAGR in terms of revenue, the global market size will reach US$ 492.2 million by 2024, from US$ 528.5 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Atropine business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Atropine market by product type, application......
  • Global Epinephrine Market Growth 2019-2024
    Published: 20-Nov-2019        Price: US 3660 Onwards        Pages: 163
    According to this study, over the next five years the Epinephrine market will register a 7.4% CAGR in terms of revenue, the global market size will reach US$ 3131.7 million by 2024, from US$ 2354.1 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Epinephrine business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Epinephrine market by product type, a......
  • Global Zika Virus Testing Market Study 2016-2026, by Segment (Molecular Test, Serologic Test) , by Market (Diagnostic Centers, Hospitals,) , by Company (Latin America, North Amercia,)
    Published: 19-Nov-2019        Price: US 1800 Onwards        Pages: 57
    Summary Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don't get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people mi......
  • Global Vincamine Market Study 2016-2026, by Segment (Vincamine Tablets, Vincamine Capsules) , by Market (Vincamine 10 mg, Vincamine 30 Mg) , by Company (Biofarm, Rompharm Company,)
    Published: 19-Nov-2019        Price: US 1800 Onwards        Pages: 47
    Summary Vincamine is a natural nootropic supplement which is found in the Periwinkle plant (Vinca Minor). It was first extracted in industrial quantities by a team of scientists examining compounds that had vasoactive properties in 1955. The global Vincamine market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): - Vincamine Tablets......
  • Global Urokinase Market Study 2016-2026, by Segment (Urokinase Powder, Urokinase Solution) , by Market (Hospital, Clinic,) , by Company (Wanhua Biochem, NDPharm,)
    Published: 19-Nov-2019        Price: US 1800 Onwards        Pages: 56
    Summary Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine pro......
  • Global Thin Film Drugs Market Study 2016-2026, by Segment (Transdermal Film, Oral Thin Film,) , by Market (Hospitals, Drugstores,) , by Company (LTS, GSK,)
    Published: 19-Nov-2019        Price: US 1800 Onwards        Pages: 64
    Summary Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intestines. A film is prepared using hydrophilic polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made. The global Thin Film Drugs market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.......
  • Global Thin Film Drug Market Study 2016-2026, by Segment (Transdermal Film, Oral Thin Film,) , by Market (Hospitals, Drugstores,) , by Company (GSK, LTS,)
    Published: 19-Nov-2019        Price: US 1800 Onwards        Pages: 67
    Summary Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intestines. A film is prepared using hydrophilic polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made. The global Thin Film Drug market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs